Supporting Your COVID-19 Therapy Development

Research aims to identify novel dermocosmetic active ingredients via unique microbiome-on-a-chip technology.

With its expertise in polymer chemistry, R&D-capabilities and its commitment in developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Softgels, Skin-Delivery and Biologics. BASF is the leading supplier of select APIs such as ibuprofen and omega-3.

Market entrance with biotech-based natural vanillin, valencene and nootkatone.

The active ingredient is a 100% natural extract from the chaga mushroom, obtained using an innovative eco-friendly technology: subcritical water extraction.

Nitrosamine Risk Assessments for pharmaceutical excipients are now available for instant download in RegXcellence™️. These statements provide increased transparency to our customers and help to better understand the potential for Nitrosamine formation and presence.

2’-FL a very promising agent for digestive health across various age groups beyond infancy.

The ingredients are extracted from the first organically certified rambutan gardens in Vietnam.

Local competence in application and formulation technology for sub-Saharan African personal care market.

B2B Cosmetics will contribute their Emuage technology, which has received the “Innovation Award” at the trade show Consumer Electronics Show (CES) in Las Vegas.

New active ingredients coming from the research of BASF’s innovation platforms on epigenetics, microbiome and extraction.